Explore tweets tagged as #Eyecelerator2023
@medevise_live
Medevise
2 years
Our team left #Eyecelerator and #ASCRS inspired! Thanks to the organizers and other attendees for making this year's congress valuable and enjoyable. #ascrs2023 #eyecelerator2023 #ophthalmicinnovation #ophthalmology #ophthalmologydevices #medicaldevices #innovation
0
0
5
@experimentica
Experimentica
2 years
Join us at Eyecelerator 2023 in SF, CA on November 2, 2023. Connect with Giedrius Kalesnykas, Guillaume Demarne, and Jeff Jamison to explore your ocular drug development programs. Can't make it in person? Let's schedule a Teams meeting. #Eyecelerator2023
Tweet media one
0
0
0
@Healio_OSN
Ocular Surgery News
2 years
In this Healio Video Perspective from #Eyecelerator2023, Patricia Buehler, MD, presents Ziplyft, her own innovative device for blepharoplasty. #OcularSurgeryNews .
0
0
0
@Healio_OSN
Ocular Surgery News
2 years
In this Healio Video Perspective from #Eyecelerator2023, Bennett Walton, MD, presents the early results of toric patients treated by Stephen Slade, MD, and himself with the Lensar Ally system. #OcularSurgeryNews.
0
0
0
@Healio_OSN
Ocular Surgery News
2 years
In this Healio Video Perspective from #Eyecelerator2023, Rajesh K. Rajpal, MD, discusses the Elita femtosecond laser from Johnson & Johnson Vision. #OcularSurgeryNews #RefractiveSurgery.
0
0
0
@Healio_OSN
Ocular Surgery News
2 years
WATCH: Anthony Wallace of @BauschLomb overviews three recently launched refractive cataract technologies from the company at #Eyecelerator2023. 👁️. 🔗 below:.#OcularSurgeryNews #CataractSurgery #Cornea @aao_ophth .
0
0
4
@Healio_OSN
Ocular Surgery News
2 years
To move forward successfully, venture capitalists interested in eye care need to be prepared to support longer development cycles, according to a speaker here at #Eyecelerator2023. 📈. Read more 🔽:.#OcularSurgeryNews #AAO2023 @aao_ophth.
0
1
2
@Healio_OSN
Ocular Surgery News
2 years
WATCH: @AceVisionGroup provides an update on the development of the VisioLite ophthalmic laser for #presbyopia, for which the company is in a Series B2 round of funding. 🔗 below:.#OcularSurgeryNews #AAO2023 #Eyecelerator2023 @AnnMarieHipsley.
0
0
1
@Healio_OSN
Ocular Surgery News
2 years
WATCH: Megan Baldwin, PhD, of @OptheaLimited shares an update on #sozinibercept, a VEGF-C/D inhibitor for the treatment of neovascular #AMD at #Eyecelerator2023. 👁️. 🔗 below:.#OcularSurgeryNews #Retina #MedWatch @aao_ophth.
0
0
1